Technology News and Research

RSS

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Aquavit Pharmaceuticals, Inc. announces it has signed a definitive licensing agreement with U-Bio Med Inc., a medical technology device company in South Korea, for the worldwide commercialization of the company's microneedle device technology.

19 Jul 2013

Safe Life FZC employs NanoSeptic self-cleaning products to combat MERS outbreak

Safe Life FZC, a new breed of healthcare distributors based in United Arab Emirates, is employing the latest technology to combat dangerous outbreaks like the deadly Coronavirus or MERS (Middle East Respiratory Syndrome).

18 Jul 2013

Audentes Therapeutics closes $30 million Series A financing

Audentes Therapeutics, Inc., a recently founded biotechnology company dedicated to the development of innovative treatments for rare muscle diseases, today announced the closing of a $30 million Series A financing.

18 Jul 2013

First Edition: July 18, 2013

Today's headlines include reports about the House vote to delay the health law's mandates as well as advance coverage of President Barack Obama's Thursday speech in which he touts the overhaul's benefits.

18 Jul 2013

Ablynx initiates additional Phase I studies with anti-RSV Nanobody ALX-0171

Activaero GmbH, the therapeutic area specialist for respiratory diseases focusing on novel, pharmacoeconomically meaningful treatment solutions, today announced that its partner Ablynx NV has initiated additional Phase I studies with its anti-RSV Nanobody ALX-0171 using Activaero's FAVORITE inhalation approach.

18 Jul 2013

Stanford Hospital & Clinics recognized as one of nation's most wired hospitals

Stanford Hospital & Clinics has again been recognized as one of the nation's "most wired" hospitals and health systems by Hospitals & Health Networks, a trade magazine published by the American Hospital Association. Stanford Hospital & Clinics is one of only 13 systems in California and among 289 nationwide to receive the honor.

18 Jul 2013

Inovio's electroporation technology enhances ability of DNA therapy to stimulate blood vessel growth

Inovio Pharmaceuticals, Inc. announced today that the use of its proprietary electroporation technology significantly enhanced the ability of a DNA therapy to stimulate blood vessel growth, which may be beneficial for the treatment of critical limb ischemia and other forms of peripheral arterial disease.

18 Jul 2013

Health law computer database 'hub' links 7 agencies, spurs privacy concerns

A computer system designed to determine which Americans get what subsidies to help them buy health coverage will be hugely important to the success or failure of Obamacare, Bloomberg reports. And new federal data show doctors have filed more than 190 million prescriptions electronically.

18 Jul 2013

Scientists develop iKnife that helps surgeons identify cancerous tissues

Scientists have developed an "intelligent knife" that can tell surgeons immediately whether the tissue they are cutting is cancerous or not.

18 Jul 2013

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

Scientists at the University of Massachusetts Medical School are the first to establish that a naturally occurring X chromosome "off switch" can be rerouted to neutralize the extra chromosome responsible for trisomy 21, also known as Down syndrome, a genetic disorder characterized by cognitive impairment.

18 Jul 2013

Breast cancer pilot study: Patients benefit from treatments guided by molecular profiling

The Side-Out Foundation's breast cancer pilot study, led by the Translational Genomics Research Institute, Translational Drug Development and Scottsdale Healthcare, has shown that cancer patients do better when their treatment is guided by molecular profiling.

18 Jul 2013

Innovative manufacturing technologies increase demand for gluten-free foods

New technologies and ingredients are improving the taste, appearance and nutritional content of gluten-free food products, a market that is expected to grow to $6 billion by 2017, according to a presentation today at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Food Expo- in Chicago.

18 Jul 2013

Spectrum researchers closer to predicting patients’ risk for heart attacks

We may be closer to predicting who is at risk for a heart attack, according to a recently published Spectrum Health study. Researchers with Spectrum Health's Frederik Meijer Heart & Vascular Institute used new imaging technology on patients being treated for heart attacks.

18 Jul 2013

Cost of emergency room visits for severe dizziness projected to reach $4.4 billion by 2015

A new Johns Hopkins research report says emergency room visits for severe dizziness have grown exponentially in recent years, with costs topping $3.9 billion in 2011 and projected to reach $4.4 billion by 2015.

18 Jul 2013

Seafood provides essential nutrients but consumers still keep watchful eye on safety

Seafood continues to be a proven strong nutrient-rich food providing essential vitamins, minerals and omega-3 fatty acids, but consumers and some toxicologists still keep a watchful eye on safety, according to a July 16 panel discussion at the 2013 Institute of Food Technologists (IFT) Annual Meeting & Food Expo- held at McCormick Place.

18 Jul 2013

Engineered liver tissue developed at MIT could help scientists test new drugs, vaccines for malaria

Although malaria has been eradicated in many countries, including the United States, it still infects more than 200 million people worldwide, killing nearly a million every year. In regions where malaria is endemic, people rely on preventive measures such as mosquito netting and insecticides. Existing drugs can help, but the malaria parasite is becoming resistant to many of them.

18 Jul 2013

AbGenomics raises $9.6M for advancing therapeutic antibodies for autoimmune diseases, cancers

AbGenomics International announced today that it has raised $9.6 million in current financing round.

18 Jul 2013

Drug that spurs cancer cells to self-destruct is on road to human clinical trials

Thanks to a new $2 million investment, a drug that spurs cancer cells to self-destruct while sparing healthy cells is on the road to human clinical trials. The compound, known as PAC-1, has so far proven safe and has promising anti-cancer effects in cell culture, in mouse models of cancer and in pet dogs with spontaneously occurring lymphomas and osteosarcomas.

18 Jul 2013

Study shows CMEs can predict risk of cancer in type 2 diabetes patients

Certain chromosomal abnormalities of the preleukemic type appear to be over-represented in patients with type 2 diabetes (T2D) who are suffering from vascular complications. This finding may provide a partial explanation for the higher rates of cancer-related mortality observed among patients with this type of diabetes.

18 Jul 2013

Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, announced today that it has signed an exclusive license agreement with the University of Maryland, Baltimore for a novel drug delivery platform, Nano-Polymer-Drug Conjugate Systems.

17 Jul 2013

Technology News and Research

Aquavit Pharmaceuticals signs licensing agreement with U-Bio Med for microneedle technology

Safe Life FZC employs NanoSeptic self-cleaning products to combat MERS outbreak

Audentes Therapeutics closes $30 million Series A financing

First Edition: July 18, 2013

Ablynx initiates additional Phase I studies with anti-RSV Nanobody ALX-0171

Stanford Hospital & Clinics recognized as one of nation's most wired hospitals

Inovio's electroporation technology enhances ability of DNA therapy to stimulate blood vessel growth

Health law computer database 'hub' links 7 agencies, spurs privacy concerns

Scientists develop iKnife that helps surgeons identify cancerous tissues

Discovery provides evidence that genetic defect responsible for Down syndrome can be suppressed

Breast cancer pilot study: Patients benefit from treatments guided by molecular profiling

Innovative manufacturing technologies increase demand for gluten-free foods

Spectrum researchers closer to predicting patients’ risk for heart attacks

Cost of emergency room visits for severe dizziness projected to reach $4.4 billion by 2015

Seafood provides essential nutrients but consumers still keep watchful eye on safety

Engineered liver tissue developed at MIT could help scientists test new drugs, vaccines for malaria

AbGenomics raises $9.6M for advancing therapeutic antibodies for autoimmune diseases, cancers

Drug that spurs cancer cells to self-destruct is on road to human clinical trials

Study shows CMEs can predict risk of cancer in type 2 diabetes patients

Rexahn Pharmaceuticals signs license agreement with UMB for novel drug delivery platform

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News